Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

Saved in:
Bibliographic Details
Title: Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.
Authors: Bidard, F.-C.1, Mathiot, C.1,2, Degeorges, A.3, Etienne-Grimaldi, M.-C.4, Delva, R.5, Pivot, X.6, Veyret, C.7, Bergougnoux, L.8, de Cremoux, P.3, Milano, G.4, Pierga, J.-Y.1,9 jean-yves.pierga@curie.net
Source: Annals of Oncology. Sep2010, Vol. 21 Issue 9, p1765-1771. 7p. 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdq052